Basic Information
ChromaCure will launch a drug development program to identify potential new candidate drugs that can selectively and effectively inhibit cancer targets and may provide new therapies for various forms of cancer, either as a single therapy or in combination with immunotherapy or chemotherapy.
ChromoCure,Inc.
Hainaut,Walloonregion,Belgium
unclear
January 01, 2018
--